Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : BCRX: Target practice for shorts -- Ignore unavailable to you. Want to Upgrade?

To: Doorman who wrote (39)	8/18/1999 6:01:00 PM
From: Sober	Respond to of 96

Next great vacine stock. If you are going to leave BCRX now that it has peaked to the projected high, you might want to take a chance with this company, which is at a stage where you could once again enjoy the run up you enjoyed here. It may take some time, but the following announcement is only hours old and the stock sold off on the news, to a point where this is a REAL bargin, and how knows, this could be the next BCRX. ________________________________________________ Company Press Release Zaxis International Inc. Makes Announcement HUDSON, Ohio--(BUSINESS WIRE)--Aug. 17, 1999--Zaxis International Inc. (OTC Bulletin Board: ZAXS - news) based here announced that its wholly-owned subsidiary, Zaxis Inc., has signed a joint letter of intent with Vaccine Solutions Pty. Ltd. of Herston, Queensland, Australia, to negotiate to obtain exclusive world rights to six antigens for malaria, which if effective, could possibly result in a vaccine for malaria. _______________________________________________________ see the entire story and more info at the ZAXS news and profile site here on Yahoo. Good luck. Yes, I do have a postion in ZAXS and you should also do your DD to assure yourself that this is something which fits your portfolio. Sober